Accordini Simone, Corsico Angelo Guido, Calciano Lucia, Bono Roberto, Cerveri Isa, Fois Alessandro, Pirina Pietro, Tassinari Roberta, Verlato Giuseppe, de Marco Roberto
Unit of Epidemiology and Medical Statistics, Department of Public Health and Community Medicine, University of Verona, Verona, Italy.
Division of Respiratory Diseases, IRCCS "San Matteo" Hospital Foundation, University of Pavia, Pavia, Italy.
BMC Pulm Med. 2015 Feb 12;15:10. doi: 10.1186/s12890-015-0008-0.
Chronic respiratory diseases are a significant cause of morbidity and mortality worldwide. We sought to evaluate the impact of asthma, chronic bronchitis and allergic rhinitis on all-cause hospitalizations and limitations in daily activities in adults.
In the Gene Environment Interactions in Respiratory Diseases study (2007/2010), a screening questionnaire was mailed to 9,739 subjects aged 20-44 (response rate: 53.0%) and to 3,480 subjects aged 45-64 (response rate: 62.3%), who were randomly selected from the general population in Italy. The questionnaire was used to: identify the responders who had asthma, chronic bronchitis, allergic rhinitis or asthma-like symptoms/dyspnoea/other nasal problems; evaluate the total burden [use of hospital services (at least one ED visit and/or one hospital admission) and number of days with reduced activities (lost working days and days with limited, not work related activities) due to any health problems (apart from accidents and injuries) in the past three months]; evaluate the contribution of breathing problems to the total burden (hospitalizations and number of days with reduced activities specifically due to breathing problems).
At any age, the all-cause hospitalization risk was about 6% among the subjects without any respiratory conditions, it increased to about 9-12% among the individuals with allergic rhinitis or with asthma-like symptoms/dyspnoea/other nasal problems, and it peaked at about 15-18% among the asthmatics with chronic bronchitis aged 20-44 and 45-64, respectively. The expected number of days with reduced activities due to any health problems increased from 1.5 among the subjects with no respiratory conditions in both the age classes, to 6.3 and 4.6 among the asthmatics with chronic bronchitis aged 20-44 and 45-64, respectively. The contribution of breathing problems to the total burden was the highest among the asthmatics with chronic bronchitis (23-29% of the hospitalization risk and 39-50% of the days with reduced activities, according to age).
The impact of asthma, chronic bronchitis and allergic rhinitis on all-cause hospitalizations and limitations in daily activities is substantial, and it is markedly different among adults from the general population in Italy. The contribution of breathing problems to the total burden also varies according to the respiratory condition.
慢性呼吸道疾病是全球发病和死亡的重要原因。我们试图评估哮喘、慢性支气管炎和过敏性鼻炎对成人全因住院率及日常活动受限情况的影响。
在“呼吸道疾病基因与环境相互作用研究”(2007/2010)中,向从意大利普通人群中随机选取的9739名20 - 44岁受试者(应答率:53.0%)和3480名45 - 64岁受试者(应答率:62.3%)邮寄了筛查问卷。该问卷用于:识别患有哮喘、慢性支气管炎、过敏性鼻炎或哮喘样症状/呼吸困难/其他鼻部问题的应答者;评估总负担[使用医院服务情况(至少一次急诊就诊和/或一次住院)以及过去三个月因任何健康问题(不包括事故和伤害)导致活动减少的天数(工作日损失天数以及有限的、与工作无关活动的天数)];评估呼吸问题对总负担的贡献(因呼吸问题导致的住院率及活动减少天数)。
在任何年龄段,无任何呼吸道疾病的受试者全因住院风险约为6%,患有过敏性鼻炎或哮喘样症状/呼吸困难/其他鼻部问题的个体该风险增至约9% - 12%,而患有慢性支气管炎的哮喘患者中,20 - 44岁和45 - 64岁年龄组的该风险分别达到峰值约15% - 18%。两个年龄组中,无呼吸道疾病的受试者因任何健康问题导致活动减少的预期天数为1.5天,而患有慢性支气管炎的哮喘患者中,20 - 44岁和45 - 64岁年龄组这一数字分别为6.3天和4.6天。呼吸问题对总负担的贡献在患有慢性支气管炎的哮喘患者中最高(根据年龄,占住院风险的23% - 29%,占活动减少天数的39% - 50%)。
哮喘、慢性支气管炎和过敏性鼻炎对全因住院率及日常活动受限情况的影响很大,且在意大利普通人群的成年人中差异显著。呼吸问题对总负担的贡献也因呼吸道疾病状况而异。